Evidence map›Paper›PMID 36452320›Full record

ArticleFrontiers in endocrinology2022

Correlation between estimated glucose disposal rate and in-stent restenosis following percutaneous coronary intervention in individuals with non-ST-segment elevation acute coronary syndrome.

Chi Liu, Qi Zhao, Ziwei Zhao, Xiaoteng Ma, Yihua Xia, Yan Sun, Dai Zhang, Xiaoli Liu, Yujie Zhou

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Chi LiuDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Qi ZhaoDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Ziwei ZhaoDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Xiaoteng MaDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Yihua XiaDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Yan SunDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Dai ZhangDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Xiaoli LiuDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Yujie ZhouDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Capital Medical University · CNBeijing Anzhen Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Insulin resistance (IR) is closely associated with in-stent restenosis (ISR) following percutaneous coronary intervention (PCI). Nevertheless, the predictive power of the newly developed simple assessment method for IR, estimated glucose disposal rate (eGDR), for ISR after PCI in individuals with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) remains unclear. Methods: NSTE-ACS cases administered PCI in Beijing Anzhen Hospital between January and December 2015 were enrolled. The included individuals were submitted to at least one coronary angiography within 48 months after discharge. Patients were assigned to 2 groups according to ISR occurrence or absence. eGDR was derived as 21.16 - (0.09 * waist circumference [cm]) - (3.41 * hypertension) - (0.55 * glycated hemoglobin [%]). Multivariate logistic regression analysis and receiver operating characteristic (ROC) curve analysis were performed for evaluating eGDR's association with ISR. Results: Based on eligibility criteria, 1218 patients were included. In multivariate logistic analysis, the odds ratios (ORs) of eGDR as a nominal variate and a continuous variate were 3.393 (confidence interval [CI] 2.099 - 5.488, P < 0.001) and 1.210 (CI 1.063 - 1.378, P = 0.004), respectively. The incremental effect of eGDR on ISR prediction based on traditional cardiovascular risk factors was reflected by ROC curve analysis (AUC: baseline model + eGDR 0.644 vs. baseline model 0.609, P for comparison=0.013), continuous net reclassification improvement (continuous-NRI) of -0.264 (p < 0.001) and integrated discrimination improvement (IDI) of 0.071 (p = 0.065). Conclusion: In NSTE-ACS cases administered PCI, eGDR levels show an independent negative association with increased ISR risk.

Indexed as

Acute Coronary SyndromeCoronary RestenosisInsulin ResistancePercutaneous Coronary InterventionGlucoseHeart Disease Risk FactorsHumansGlucoseestimated glucose disposal ratein-stent restenosisinsulin resistancenon-ST-segment elevation acute coronary syndromepercutaneous coronary intervention

Identifiers

PMID36452320
PMCPMC9702552
OpenAlexW4309011903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.